Herbas VPB

Print
EN | LT
LT - USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
EN - USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/40 (2006.01)
A61K2039/505 (2013.01)
A61K 39/395 (2006.01)
A61K2039/545 (2013.01)
A61P 3/06 (2006.01)
C07K 16/40 (2013.01)
A61P 3/06 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3689913
(13) Kind of document T
(96) European patent application number 19210918.9
Date of filing the European patent application 2014-10-10
(97) Date of publication of the European application 2020-08-05
(45) Date of publication and mention of the grant of the patent 2022-03-23
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201361890154 P 2013-10-11 US
201461923103 P 2014-01-02 US
201461955514 P 2014-03-19 US
201462004620 P 2014-05-29 US
201462025104 P 2014-07-16 US
14306221 2014-07-31 EP
201462054571 P 2014-09-24 US
14306584 2014-10-09 EP
Inventors
(72)
BACCARA-DINET, Marie , FR
BESSAC, Laurence , FR
CHAUDHARI, Umesh , US
HANOTIN, Corinne , FR
PORDY, Robert C. , US
SASIELA, William J. , US
SCHWEMMER GIPE, Daniel A. , US
Grantee
(73) Sanofi Biotechnology , 54 rue La Boétie, 75008 Paris, FR
Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Title
(54) USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
  USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA